Sites of the Helmholtz Centre
The Sites of the Helmholtz Centre for Infection Research are distributed all over Germany. In addition to the main campus in Braunschweig, there are facilities in five other cities: Hamburg, Hanover, Saarbrücken, Würzburg and Greifswald.
The vision of the Centre for Individualised Infection Medicine (CiiM) is to individualise the management of infectious diseases. CiiM is a joint venture of the Helmholtz Centre for Infection Research (HZI) and the Hannover Medical School (MHH) and was founded as an initially virtual network in 2015. Research activities at the center aim to identify individual parameters that influence the progress of infection and to translate these findings into optimized and individualised care of patients with infectious diseases.
Find detailed information on the Centre for Individualised Infection Medicine at: https://www.ciim-hannover.de/en/
The research at the CiiM aims to consequently promote personalisation of health care in infection medicine.
In individualised medicine specific requirements of patients or patient groups are taken into account for an optimal risk-benefit assessment and subsequently improved therapy outcome. Systematic diagnostics allow the stratification of patients and thereby targeted prevention and tailored therapies.
The potential of personalised approaches in infection medicine is currently being underutilised. But individual parameters as age, pre-existing conditions or genetic and physiological prerequisites have a substantial effect on the course of disease.
The existing translational expertise in the Hannover-Braunschweig region, modern technology platforms and infrastructures including relevant patient cohorts offer optimal conditions to establish the CiiM as an internationally leading centre for individualised infection medicine.
Being initially a virtual centre, the new CiiM groups will be housed at TWINCORE and will utilise infrastructures of the parental institutions to align, coordinate and further expand research activities in the field of personalised medicine. With the help of the established CiiM faculty team building among involved MHH, HZI and TWINCORE groups will be promoted as well as the coordinated expansion of infrastructure and target-aimed initial appointments for key disciplines will be made.
In order to successfully and sustainably implement the concept of individualised infection medicine, a completely new quality of cooperation and technological equipment is required. Therefore, a modern laboratory building is to be built in close proximity to Hannover Medical School and TWINCORE, in which research activities will be linked and the CiiM working groups brought together.
A research building with a total investment sum of EUR 24.9 million can be realised with the provision of EUR 18.4 million via the Helmholtz Association, a special commitment of EUR 5 million from the State of Lower Saxony and a contribution of EUR 1.5 million from the HZI. The building site will be provided by MHH.